NGL Granted Provisional Authorisation for COVID-19 Diagnostic Tests
HSA Expedites Approval of COVID-19 Diagnostic Tests in Singapore via Provisional Authorisation
The Health Sciences Authority (HSA) is committed to ensuring the rapid availability of diagnostic tests for COVID-19 in Singapore. Since 29 January 2020, HSA has been closely providing regulatory and scientific advice to research institutions as well as local and multi-national companies to ensure the timely availability of good quality performing test kits that are critical during this period of need.
Novena Global Lifecare has been granted provisional authorisation for the Fosun Novel Coronavirus (2019-nCoV) RT-PCR Detection Kit
This RT-PCR detection kit is intended for the rapid detection of 2019-nCOV in human throat swab or sputum samples. The kit is intended for the detection of 2019-nCOV and is helpful for clinical diagnosis of 2019-nCOV infection.
For more information, view the full Health Science Authority announcement